Cyclobenzaprine Hydrochloride
Product Images NDC 66116-527

2 FDA label images from Medvantx, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 66116-527). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medvantx, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (6a682677 4a99 43a5 A991 Af7f2d69aca1 01)

Structural Formula (6a682677 4a99 43a5 A991 Af7f2d69aca1 01)
Chemical structure of Cyclobenzaprine Hydrochloride, showing the tricyclic ring system with the chemical formula for the hydrochloride salt side chain.*
FDA Label Image

Cyclobenzaprine HCl 10mg Tablets #30 (6a682677 4a99 43a5 A991 Af7f2d69aca1 02)

Cyclobenzaprine HCl 10mg Tablets #30 (6a682677 4a99 43a5 A991 Af7f2d69aca1 02)
Label for Cyclobenzaprine Hydrochloride Tablets USP 10 mg, packaged as 30 tablets. The label shows the product name, strength, and quantity, along with storage instructions to keep at controlled room temperature (20°-25°C). It is labeled for prescription use only and distributed by MedVantx, Inc. The label includes contact information for MedStart Connect and mentions Teva Pharmaceuticals USA as the manufacturer for distribution.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.